Related Experiment Video
Updated: May 25, 2026

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
Insights
Histone deacetylases (HDACs) overexpressed in chronic lymphocytic leukemia (CLL) silence crucial microRNAs (miRs), promoting cancer cell survival. HDAC inhibition emerges as a promising therapeutic strategy for treating CLL.
Area of Science:
- Molecular Biology
- Oncology
- Hematology
Background:
- Chronic lymphocytic leukemia (CLL) is a B-cell malignancy characterized by the accumulation of malignant B cells.
- MicroRNAs (miRs) play critical roles in gene regulation and are often dysregulated in cancer.
- The mechanisms of miR silencing in CLL have not been fully elucidated.
Discussion:
- Sampath and colleagues identify histone deacetylases (HDACs) as key regulators of miR silencing in CLL.
- Overexpressed HDACs in CLL B cells are shown to block the expression of critical tumor-suppressive miRs.
- This blockade results in the activation of pro-survival signaling pathways, contributing to CLL pathogenesis.
Key Insights:
- HDACs directly inhibit the expression of specific miRs in malignant B cells in CLL.
- Silencing of these miRs by HDACs promotes the survival of CLL cells.
- This study reveals a novel mechanism of oncogenesis in CLL mediated by HDACs and miR dysregulation.
Outlook:
- HDAC inhibition represents a potential therapeutic strategy for CLL.
- Targeting HDACs may restore miR expression and induce apoptosis in CLL cells.
- Further research is warranted to explore the clinical efficacy of HDAC inhibitors in CLL treatment.
Abstract:
In this issue of Blood, Sampath and colleagues provide an important missing link in how microRNAs (miRs) can be silenced in chronic lymphocytic leukemia (CLL):histone deacetylases (HDACs) that are overexpressed in CLL block critical miRs in the malignant B cell resulting in pro-survival signals. Thus,HDAC inhibition is an attractive new therapeutic strategy in CLL.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
22:27Hi-C: A Method to Study the Three-dimensional Architecture of Genomes.
Published on: May 6, 2010
Related Concept Videos
Catalysis
Catalysis
X-Inactivation
X-inactivation
Anaphase Promoting Complex
Anaphase Promoting Complex